|
๐
|
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
17 auth.
C. Antoni,
A. Kavanaugh,
B. Kirkham,
Z. Tutuncu,
G. Burmester,
U. Schneider,
D. Furst,
J. Molitor,
E. Keystone,
D. Gladman,
...
B. Manger,
S. Wassenberg,
R. Weier,
D. Wallace,
M. Weisman,
J. Kalden,
J. Smolen
|
9 |
2005 |
9
๐
|
|
๐ฆ
|
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
S. Wassenberg,
R. Rau,
P. Steinfeld,
H. Zeidler
|
8 |
2005 |
8
๐ฆ
|
|
๐
|
Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.
9 auth.
A. Zink,
A. Strangfeld,
Matthias Schneider,
P. Herzer,
F. Hierse,
M. Stoyanova-Scholz,
...
S. Wassenberg,
A. Kapelle,
J. Listing
|
7 |
2006 |
7
๐
|
|
๐
|
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year
13 auth.
A. Kavanaugh,
C. Antoni,
D. Gladman,
S. Wassenberg,
B. Zhou,
A. Beutler,
G. Keenan,
G. Burmester,
D. Furst,
M. Weisman,
...
J. Kalden,
J. Smolen,
D. Heijde
|
7 |
2006 |
7
๐
|
|
๐
|
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
7 auth.
J. Listing,
A. Strangfeld,
J. Kekow,
Matthias Schneider,
A. Kapelle,
S. Wassenberg,
...
A. Zink
|
7 |
2008 |
7
๐
|
|
๐
|
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
52 auth.
H. Tony,
G. Burmester,
H. Schulze-Koops,
M. Grunke,
J. Henes,
I. Kรถtter,
J. Haas,
L. Unger,
S. Lovric,
M. Haubitz,
R. Fischer-Betz,
G. Chehab,
A. Rubbert-Roth,
C. Specker,
J. Weinerth,
...
J. Holle,
U. Muฬller-Ladner,
R. Kรถnig,
C. Fiehn,
P. Burgwinkel,
K. Budde,
H. Sรถrensen,
M. Meurer,
M. Aringer,
B. Kieseier,
C. Erfurt-Berge,
M. Sticherling,
R. Veelken,
U. Ziemann,
F. Strutz,
P. von Wussow,
F. Meier,
N. Hunzelmann,
E. Schmidt,
R. Bergner,
A. Schwarting,
R. Eming,
M. Hertl,
R. Stadler,
M. Schwarz-Eywill,
S. Wassenberg,
M. Fleck,
C. Metzler,
U. Zettl,
J. Westphal,
S. Heitmann,
A. L. Herzog,
H. Wiendl,
W. Jakob,
Elvira Schmidt,
K. Freivogel,
T. Dรถrner
|
7 |
2011 |
7
๐
|
|
๐
|
Induction therapy with adalimumab plus methotrexate for 24โ
weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naรฏve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
18 auth.
J. Detert,
H. Bastian,
J. Listing,
A. Weiร,
S. Wassenberg,
A. Liebhaber,
K. Rockwitz,
R. Alten,
K. Krรผger,
R. Rau,
...
C. Simon,
E. Gremmelsbacher,
T. Braun,
Bettina Marsmann,
V. Hรถhne-Zimmer,
K. Egerer,
F. Buttgereit,
G. Burmester
|
7 |
2012 |
7
๐
|
|
๐ฌ
|
A new method of scoring radiographic change in rheumatoid arthritis.
Rolf Rau,
S. Wassenberg,
G. Herborn,
Gerold Stucki,
A. Gebler
|
7 |
1998 |
7
๐ฌ
|
|
๐
|
Treatment continuation in patients receiving biological agents or conventional DMARD therapy
14 auth.
A. Zink,
J. Listing,
S. Kary,
P. Ramlau,
M. Stoyanova-Scholz,
K. Babinsky,
U. V. Hinueber,
E. Gromnica-ihle,
S. Wassenberg,
C. Antoni,
...
P. Herzer,
J. Kekow,
M. Schneider,
R. Rau
|
7 |
2005 |
7
๐
|
|
๐ฌ
|
Psoriatic arthritis imaging: a review of scoring methods
D. V. D. Heijde,
J. Sharp,
S. Wassenberg,
D. Gladman
|
7 |
2005 |
7
๐ฌ
|
|
๐
|
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
21 auth.
C. Antoni,
A. Kavanaugh,
D. M. van der Heijde,
A. Beutler,
G. Keenan,
Bei Zhou,
B. Kirkham,
Z. Tutuncu,
G. Burmester,
U. Schneider,
...
D. Furst,
J. Molitor,
E. Keystone,
D. Gladman,
B. Manger,
S. Wassenberg,
R. Weier,
D. Wallace,
M. Weisman,
J. Kalden,
J. Smolen
|
7 |
2008 |
7
๐
|
